Publications
Tzung S-P, Kim K, Basanez G, Giedt C, Simon J, Zimmerberg J, Zhang K, Hockenbery DM. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nature Cell Biol. 3: 183-191, 2001
Kim KM, Giedt CD, Basanez G, O'Neill JW, Hill JJ, Han YH, Tzung SP, Zimmerberg J, Hockenbery DM, Zhang KY. Biophysical characterization of recombinant human Bcl-2 and its interactions with an inhibitory ligand, antimycin A. Biochem 40: 4911-4922, 2001
Morrish F, Giedt C, Hockenbery DM. C-MYC apoptotic function is mediated by NRF-1 target genes. Genes and Development, 17: 240-255, 2003
Haughn, L, Hawley, RG, Morrison DK, Hockenbery DM. Bcl-2 and Bcl-xL restrict lineage choice during hematopoietic differentiation. J Biol Chem 278,2003
Manion MK, O'Neill JW, Giedt CD, Kim KM, Zhang KYJ, Hockenbery DM. Bcl-xL mutations suppress cellular sensitivity to antimycin A. J Biol Chem 279: 2159-2165, 2004
Wang H, Li M, Rhie JK, Hockenbery DM, Covey JM, Zhang R. Hill DL. Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents. Cancer Chemother Pharmacol 56: 291-8, 2005
O'Neill JW, Manion MK, Maguire B, Hockenbery DM. BCL-XL dimerization by three-dimensional domain swapping. J Mol Biol 356: 367-81, 2006
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2008 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy
.
Science & Education
Labs
Hockenbery Lab
Lab Members
Publications
Research Projects
Conjoint 541 Course
